Back to School for Biotech
How Academia and Industry Can Collaborate to Advance Biologic Drug Development and Manufacturing
The Shifting Field of Stem Cell Regulations
Recent FDA Hearings Addressed Concerns Around Clinics Offering Cellular Therapies to Consumers
Enhancing Graduate and Postdoc Education for a Sustainable Workforce
Ph.D.-Trained Biomedical Scientists Can No Longer Count on Finding Academic Positions Upon Graduation
Unlucky 13: Top Clinical Trial Failures of 2016
In Missing Primary Endpoints, These Drugs Touched Off Stock Selloff, Layoffs, and Worse
GEN’s editor in chief, John Sterling, interviews life science academic and biotech industry leaders on important research, technology, and trends. These podcasts will keep you informed with all the important details you need.
Scientists in Ireland have solved a mystery regarding the cause of especially smelly camel urine. Their research has implications for the millions of people affected by African parasites called trypanosomes, which frequently cause death from sleeping sickness.
David G. Maloney, M.D., Ph.D., of the Fred Hutchinson Cancer Research Center and Seattle Cancer Care Alliance, discusses the new Bezos Family Immunotherapy Clinic, a first-of-its-kind facility focused on providing cancer immunotherapies to patients.
Findings from a new retrospective study has found that active marijuana use could increase the risk for developing a rare cardiovascular event.
A new computer analysis from investigators at the MD Anderson Cancer Center suggests that traces of long-lost human cousins may be buried in modern people’s DNA.
Mary Woolley, President of Research!America, which advocates for medical and health research funding, discusses key issues in research that the next president is likely to confront. How can researchers keep those issues on the national agenda no matter who wins on Election Day?
A new study from investigators at The Ohio State University entitled “Gut dysbiosis impairs recovery after spinal cord injury,” describes the impact the gut microbiome has on spinal cord injury and how probiotics could help speed recovery.
One area where biopharma employment has been increasing is in regulatory affairs and compliance.
Quadruple helices appear to have role in switching genes on or off.
Yale University researchers have uncovered the intriguing mechanisms that underlie common sickness behaviors.
Interview with Jon Soderstrom, Ph.D., managing director of the office of cooperative research at Yale University and moderator of the BIO tech transfer session, and Atul Saran, senior vp of corporate development and ventures at MedImmune
Interview with Jim Vaught, Ph.D., Deputy Director, NCI Office of Biorepositories and Biospecimen Research
Alan Russell, Ph.D., Editor in Chief
E. Morrey Atkinson, Ph.D., CSO, VP of R&D, Cook Pharmica
Jeffrey Karp, Ph.D., Co-Director, Center for Regenerative Therapeutics; Associate Bioengineer, Brigham and Women’s Hospital; and Assistant Professor, Harvard Medical School
Gholson Lyon, M.D., Ph.D., Senior Scientist, Principal Investigator, Center for Applied Genomics, The Children’s Hospital of Philadelphia
Benjamin Schuler, Ph.D., Professor of Biochemistry, University of Zurich
G. Steven Burrill, CEO, Burrill & Company
Sandy M. Simon, Ph.D., Professor, Laboratory of Cellular Biophysics, The Rockefeller University
Dr. Jessica Winter, Assistant Professor, Chemical and Biomolecular Engineering and Biomedical Engineering, Ohio State University
Aris Persidis, Ph.D., President, Biovista